Form 4: Carlyle Group Sells Shares in QuidelOrtho Corp (QDEL) Under 10b5-1 Trading Plan

The Carlyle Group executed multiple sales of QuidelOrtho Corp (QDEL) common stock between August 7th and August 8th, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• The Carlyle Group, a significant shareholder of QuidelOrtho Corp (QDEL), has reported the sale of common stock.
• The sales occurred on August 7th and 8th, 2024.
• The transactions were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
• A total of 184,985 shares were sold across multiple transactions at varying prices.
• The weighted average sale prices ranged from $38.9742 to $41.3834 per share.
• Following these transactions, the Carlyle Group's indirect beneficial ownership stands at 8,334,317 shares.
• The shares are held of record by Carlyle Partners VI Cayman Holdings, L.P.
• The Carlyle Group Inc. and several related entities may be deemed to share beneficial ownership but disclaim it.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing share sales under a pre-arranged plan. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about transactions.

Industry Context

This filing indicates activity by a major shareholder, which is common in the financial markets. Monitoring such transactions can provide insights into investor sentiment and potential future stock performance.

Stakeholder Impact

• The share sales by a major shareholder like Carlyle Group could potentially influence investor sentiment and the stock price of QuidelOrtho Corp.

Key Dates